The Business Research Company’s Artificial Intelligence (AI) In Medical Writing Market Report 2026 – Market Size, Trends, And Global Forecast 2026-2035
LONDON, GREATER LONDON, UNITED KINGDOM, April 30, 2026 /EINPresswire.com/ — “Artificial Intelligence (AI) In Medical Writing market to surpass $2 billion in 2030. In comparison, the Artificial Intelligence market, which is considered as its parent market, is expected to be approximately $302 billion by 2030, with Artificial Intelligence (AI) In Medical Writing to represent around 1% of the parent market. Within the broader Information Technology industry, which is expected to be $13,807 billion by 2030, the Artificial Intelligence (AI) In Medical Writing market is estimated to account for nearly 0.01% of the total market value.
Which Will Be The Biggest Region In The Artificial Intelligence (AI) In Medical Writing Market In 2030?
North America will be the largest region in the artificial intelligence (AI) in medical writing market in 2030, valued at $0.74 billion. The market is expected to grow from $0.39 billion in 2025 at a compound annual growth rate (CAGR) of 14%. The rapid growth can be attributed to increasing adoption of AI-driven automation in regulatory documentation, rising demand for faster and more accurate clinical and scientific writing, growing investments in healthcare digitalization, expanding pharmaceutical and biotechnology research activities, and the integration of natural language processing technologies to enhance efficiency and reduce operational costs.
Which Will Be The Largest Country In The Global Artificial Intelligence (AI) In Medical Writing Market In 2030?
The USA will be the largest country in the artificial intelligence (AI) in medical writing market in 2030, valued at $0.66 billion. The market is expected to grow from $0.34 billion in 2025 at a compound annual growth rate (CAGR) of 14%. The rapid growth can be attributed to increasing adoption of AI-driven tools for regulatory documentation and clinical writing, rising demand for faster and more accurate medical content generation, growing investments by pharmaceutical and biotechnology companies in digital transformation, and the country’s strong presence of advanced healthcare infrastructure and leading AI technology providers.
Request A Free Sample Of The Artificial Intelligence (AI) In Medical Writing Market Report
https://www.thebusinessresearchcompany.com/sample_request?id=16590&type=smp&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR
What Will Be The Largest Segment In The Artificial Intelligence (AI) In Medical Writing Market In 2030?
The artificial intelligence (AI) in medical writing market is segmented by type into clinical writing, scientific writing, and other types. The clinical writing market will be the largest segment of the artificial intelligence (AI) in medical writing market segmented by type, accounting for 55% or $1 billion of the total in 2030. The clinical writing market will be supported by its critical role in regulatory documentation, increasing adoption of AI-driven automation tools, growing demand from pharmaceutical and biotechnology industries, rising complexity of clinical trials, expanding need for accurate and compliant medical content, and continuous advancements in natural language processing technologies.
The artificial intelligence (AI) in medical writing market is segmented by application into regulatory documentation, automated literature review, language translation, pharmacovigilance, and content modularization.
The artificial intelligence (AI) in medical writing market is segmented by end use into medical devices, pharmaceutical, biotechnology, and other end uses.
What Is The Expected CAGR For The Artificial Intelligence (AI) In Medical Writing Market Leading Up To 2030?
The expected CAGR for the artificial intelligence (AI) in medical writing market leading up to 2030 is 15%.
What Will Be The Growth Driving Factors In The Global Artificial Intelligence (AI) In Medical Writing Market In The Forecast Period?
The rapid growth of the global artificial intelligence (AI) in medical writing market leading up to 2030 will be driven by the increasing regulatory pressure on responsible artificial intelligence practices, growing demand for ethical and transparent artificial intelligence systems, and rising legal and compliance risks related to biased algorithms, which are collectively expected to reshape compliance frameworks, risk management strategies, operational transparency, and technology adoption across pharmaceutical, biotechnology, and healthcare ecosystems.
Increasing Regulatory Pressure On Responsible Artificial Intelligence Practices – Increasing regulatory scrutiny around responsible AI is expected to be a key driver of the artificial intelligence (AI) in medical writing market by 2030. Governments and regulatory authorities are introducing frameworks that mandate documentation, monitoring, and justification of algorithmic decisions. These requirements emphasize transparency, fairness, and risk management, driving the need for advanced audit platforms capable of generating compliance-ready reports. With evolving regulations such as the EU AI Act and sector-specific guidelines, organizations must adopt solutions that ensure regulatory alignment. Bias audit platforms enable enterprises to detect discriminatory patterns, validate fairness metrics, and produce standardized audit documentation, thereby accelerating adoption across regulated industries. Consequently, the increasing regulatory scrutiny around responsible AI is projected to contribute approximately 3.0% annual growth to the market.
Growing Demand For Ethical And Transparent Artificial Intelligence Systems – The increasing emphasis on ethical and transparent AI systems is anticipated to significantly support the artificial intelligence (AI) in medical writing market by 2030. Organizations are becoming more aware of the reputational and operational risks associated with opaque or biased AI-driven decisions. Stakeholders, including customers, employees, and investors, demand explainable and fair AI outcomes. Bias audit platforms enhance visibility into model behavior, offering tools such as transparency dashboards, explainability features, and fairness assessments. As responsible AI becomes a key competitive differentiator, enterprises are increasingly investing in solutions that strengthen ethical governance and accountability. As a result, this increasing emphasis on ethical and transparent AI systems is expected to contribute around 2.8% annual growth to the market.
Increasing Legal And Compliance Risks Related To Biased Algorithms – Rising legal and compliance risks associated with biased algorithms are set to drive growth in the artificial intelligence (AI) in medical writing market by 2030. Biased AI outcomes can lead to lawsuits, regulatory penalties, and reputational damage, particularly in highly regulated sectors such as healthcare, finance, and recruitment. Organizations are under pressure to proactively manage these risks and ensure adherence to anti-discrimination laws. Bias audit platforms play a critical role by identifying bias early, validating fairness standards, and maintaining audit trails for legal and regulatory purposes. By minimizing exposure to litigation and compliance failures, these platforms act as essential risk mitigation tools. Therefore, these rising legal and compliance risks associated with biased algorithms are projected to contribute approximately 2.5% annual growth to the market.
Access The Detailed Artificial Intelligence (AI) In Medical Writing Market Report Here
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-medical-writing-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Apr_PR
What Are The Key Growth Opportunities In The Artificial Intelligence (AI) In Medical Writing Market In 2030?
The most significant growth opportunities are anticipated in the clinical writing market, the scientific writing market, and the other types market. Collectively, these segments are projected to contribute over $2.2 billion in market value by 2030, driven by increasing adoption of artificial intelligence for automating medical documentation, rising demand for regulatory-compliant and high-quality content, growing clinical trial activities and scientific research, expanding pharmaceutical and biotechnology industries, and continuous advancements in natural language processing technologies. This growth reflects the increasing focus on improving efficiency, ensuring accuracy, and accelerating time-to-market for medical and scientific communications, fuelling significant expansion within the broader artificial intelligence (AI) in medical writing market.
The clinical writing market is projected to grow by $1 billion, the scientific writing market by $1 billion, and the other types market by $0.2 billion over the next five years from 2025 to 2030.
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. We have published over 17,500 reports across 27 industries and 60+ geographies. Our research is powered by 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
We provide continuous and custom research services, offering a range of specialized packages tailored to your needs, including Market Entry Research Package, Competitor Tracking Package, Supplier & Distributor Package and much more.
Disclaimer: Please note that the findings, conclusions and recommendations that TBRC Business Research Pvt Ltd delivers are based on information gathered in good faith from both primary and secondary sources, whose accuracy we are not always in a position to guarantee. As such TBRC Business Research Pvt Ltd can accept no liability whatever for actions taken based on any information that may subsequently prove to be incorrect. Analysis and findings included in TBRC reports and presentations are our estimates, opinions and are not intended as statements of fact or investment guidance.”
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Media gallery
